Therefore, we analyzed the CD3+/FOXP3+ ratio, and found no statistically significant difference neither between tumor margin and center (p-value 0.298) nor between the relapse and non-relapse group (p-value 0.886). The gene discussed is FOXP3; the disease is neoplasm.